Oral anticoagulation reduces thromboembolic events in patients with nonvalvular atrial fibrillation (AF); however, underuse of anticoagulation is a major issue in treating patients with nonvalvular AF at high stroke risk.
As we know that Oral anticoagulant ( Warfarin) is still considered as DOC for Valvular AF. But use of warfarin in nonvalvular AF is underused because of interaction issue , compliance and PT-INR monitoring . Other DOAC ( Direct acting oral anticoagulant) are available having unique properties of shirt onset time and stop it immediately before any major Surgery
Your question asks about the reasons for underutilization. The answer is simple: there are many mediocre cardiologists. Otherwise, they would do what they are told to do via the guidelines.
The issue of anticoagulation underutilization for AF is widespread, not just in the context of TAVR
- Badges
- Science topic